SCHEMBL6501188

SCHEMBL6501188

O=C(O)C1CCN(c2cc(Br)c(F)cc2[N+](=O)[O-])CC1

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.60
MAPT P10636 7/20 0.57
MAPK1 P28482 2/20 0.57
PKM P14618 1/20 0.53
CYP2C9 P11712 2/20 0.53
CYP2C19 P33261 2/20 0.53
POLB P06746 1/20 0.53
SERPINE1 P05121 5/20 0.53
GPR174 Q9BXC1 3/20 0.51
KMT2A Q03164 1/20 0.50
GAA P10253 2/20 0.48
ALDH1A1 P00352 2/20 0.48
LMNA P02545 1/20 0.48
HTT P42858 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6509839 0.83 MAPT (0.62) TDP1MAPTMAPK1CYP2C9CYP2C19
SCHEMBL31693870 0.80 MAPK1 (0.78) MAPTMAPK1PKMCYP2C9CYP2C19
SCHEMBL4403596 0.80 TDP1 (0.74) TDP1MAPTMAPK1CYP2C9CYP2C19
SCHEMBL2559246 0.80 TDP1 (0.63) TDP1MAPTCYP2C9CYP2C19POLB
SCHEMBL26870838 0.76 MAPT (0.58) MAPTMAPK1PKMCYP2C9CYP2C19
SCHEMBL14330888 0.76 MAPT (0.53) MAPTMAPK1PKMCYP2C9CYP2C19
SCHEMBL3435981 0.76 MAPT (0.52) MAPTMAPK1PKMCYP2C9CYP2C19
SCHEMBL14206434 0.74 MAPT (0.48) MAPTMAPK1PKMGPR174KMT2A
SCHEMBL2039778 0.74 TDP1 (0.74) TDP1MAPTMAPK1CYP2C9CYP2C19
SCHEMBL2041681 0.74 MAPT (0.79) TDP1MAPTMAPK1CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005019200-A2 ARYL PIPERIDINE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-03-03 WO disclosed